SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Flexion Therapeutics Q1 EPS $(0.950) Beats $(0.990) Estimate, Sales $20.127M Beat $19.800M Estimate

Flexion Therapeutics (NASDAQ:FLXN) reported quarterly losses of $(0.950) per share which beat the analyst consensus estimate of $(0.990) by 4.04 percent. This is a 12.84 percent increase over losses of $(1.090) per share

Benzinga · 05/07/2020 21:51

Flexion Therapeutics (NASDAQ:FLXN) reported quarterly losses of $(0.950) per share which beat the analyst consensus estimate of $(0.990) by 4.04 percent. This is a 12.84 percent increase over losses of $(1.090) per share from the same period last year. The company reported quarterly sales of $20.127 million which beat the analyst consensus estimate of $19.800 million by 1.65 percent. This is a 90.52 percent increase over sales of $10.564 million the same period last year.